Pharmaceuticals
-
Cannabis clinical trial urgent – MPs
The UK needs an "immediate" clinical trial established of the benefits of medicinal cannabis for intractable childhood epilepsy, MPs have said. Read more
-
Flu threat from antibiotics
Changes in the gut bacteria caused by antibiotics may increase the risks from flu infection by weakening the immune response, scientists have warned. Read more
-
How cancer super-drugs fail
Super-drugs designed to target common gene faults in cancers may have wildly varying effects depending on the type of disease, British researchers report today. Read more
-
Myeloma heads cancer survival improvements
Survival rates for myeloma patients in England have improved dramatically this decade because of new treatments, a charity has revealed. Read more
-
Harm concerns linked to youth epilepsy treatment
Treatment guidelines for young people with epilepsy could be reviewed after a Swedish study found a group of drugs is linked to an increased risk of suicidal behaviour. Read more
-
Gene study closes in on pneumonia vaccine resistance
A major genetic research project has identified 621 strains of Streptococcus pneumoniae, it was announced last night. Read more
-
Immunotherapy hope for head and neck cancer
An immunotherapy has proved better than aggressive chemotherapy in the treatment of recurrent head and neck cancer, a conference will hear today. Read more
-
Progress on compound against superbugs
British scientists say they have found a new molecular compound that works against multidrug resistant bacteria such as E. coli. Read more
-
Gender response to chemotherapy investigated
Women given chemotherapy for oesophagogastric cancer had better survival than men – but experienced worse side effects, a UK-based research project has found. Read more
-
Gene study offers new Strep A vaccine hope
A major genetic analysis may have pin-pointed targets for vaccines against Group A streptococcus, it was announced last night. Read more
